118 results
8-K
EX-1.1
STRO
Sutro Biopharma Inc
2 Apr 24
Entry into a Material Definitive Agreement
5:10pm
-effective amendment thereto or the Rule 462(b)
Registration Statement, if any, has been issued and no proceeding for that purpose or pursuant to Section 8A … of the Stock has been issued by the Commission, and no proceeding for that purpose or pursuant to Section 8A of the Securities Act has been
8-K
EX-5.1
STRO
Sutro Biopharma Inc
2 Apr 24
Entry into a Material Definitive Agreement
5:10pm
to the Registration Statement and is not to be relied upon for any other purpose. In providing this letter, we are opining only as to the specific
424B5
STRO
Sutro Biopharma Inc
2 Apr 24
Prospectus supplement for primary offering
4:58pm
may be, or all or substantially all of the Lock-Up Party’s assets, in any such case not undertaken for the purpose of avoiding the restrictions … , each of whom is an accredited investor; or
a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
8-K
EX-99.1
STRO
Sutro Biopharma Inc
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity
8-K
EX-99.1
zi6g9kdkv
25 Mar 24
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
S-8
fdr32wde 6antjlu8
27 Feb 24
Registration of securities for employees
4:33pm
S-8
EX-5.1
t19hq1g23bmmh i6133m
27 Feb 24
Registration of securities for employees
4:33pm
S-8
yl20iait dp0
27 Feb 24
Registration of securities for employees
4:33pm
8-K
EX-5.1
krxxc 59u7
9 Feb 24
Other Events
4:27pm
8-K
EX-1.1
1i8qc8nr
9 Feb 24
Other Events
4:27pm
424B5
rpwlmg3g3p9dylg vle
9 Feb 24
Prospectus supplement for primary offering
4:25pm
8-K
EX-99.1
c8rkfi3tvje
8 Jan 24
Results of Operations and Financial Condition
7:31am
8-K
EX-99.1
gk4ua83yar0h9bb
21 Nov 23
Departure of Directors or Certain Officers
4:05pm